10 10 Chemicalname=(+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride,(+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride,CAS=CAS=1085333-94-3,Labeled API of Metanephrine,Stable Isotopes of Metanephrine, reference standards of Metanephrine| CLEARSYNTH

(+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride

STABLE ISOTOPES

Product Details

CAT No.# CS-I-00187
Category Stable Isotopes
CAS 1085333-94-3
Molecular Weight 236.71
Molecular Formula C10H16ClNO3
Stock Status: In-Stock   View COA
Synonyms: 2-methoxy-4-[1,2,2-trideuterio-1-hydroxy-2-(methylamino)ethyl]phenol hydrochloride
Storage: To be stored under - 20 deg
Shipping: Free Shipping for worldwide on order above 2000 USD
(+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride Worldwide Suppliers of (+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride Stable Isotopes Clearsynth CS-I-00187

Product rating: 9 (+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride based on 20 ratings

  1. Stable Isotopes
  2. (+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Crisaborole m-Isomer
15. Riluzole (1604337)
16. Pheniramine impurity B
17. Palbociclib N-Glucuronide
18. Carpropamid
19. Olmesartan N1-Trityl Impurity
20. Aripiprazole (1042634)


Smileys:
CNCC(C1=CC(=C(C=C1)O)OC)O.Cl



This page contains information about (+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride Cas 1085333-94-3 and its Stable Isotopes.

(+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride (+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride Worldwide Suppliers of (+/-)-Metanephrine-alpha,beta,beta D3 Hydrochloride Stable Isotopes Clearsynth 1085333-94-3

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."